• PEAK Matrix®
    Sep. 12, 2025

    Enterprises are recalibrating procurement and finance operations as cost pressures, regulatory complexity, and rapid technology advancements intensify. Procure-to-Pay (P2P) products have become integral to unifying purchasing and Accounts Payable (AP) workflows, enabling organizations to automate processes,…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…